As a fitness enthusiast, author, and father, Randy reflects on how cancer shaped his outlook on health and resilience. He offers heartfelt advice to anyone facing a diagnosis, encouraging them to take charge of their health and embrace the power of a positive mindset.
Read MoreDr. Hsieh emphasized that understanding and treating testosterone deficiency is a vital part of survivorship care for testicular cancer patients. He encouraged survivors to advocate for themselves and consult healthcare professionals to manage symptoms effectively.
Read MoreThe discussion dives into how testicular cancer’s high survival rates make addressing long-term challenges—like financial burdens, fertility concerns, and post-treatment anxieties—more important than ever. Dr. Matulewicz shares insights on innovative tools, including patient-reported surveys and proactive recovery trackers, designed to capture the full spectrum of patient experiences and improve outcomes beyond physical health.
Read MoreAustin Weimer is a testicular cancer survivor from Ohio. Austin talks about how his diagnosis was delayed due to being his original urologist's first testicular cancer patient, having chemo and an RPLND at IU, the disparities between testicular cancer and other cancers, and more!
Read MoreDr. Patel emphasized the importance of early fertility preservation discussions before any cancer treatment begins. Personalized care, thorough counseling, and access to reproductive technologies are crucial for optimizing fertility outcomes in testicular cancer survivors. Addressing both medical and psychosocial factors enables patients to make informed decisions about their reproductive health.
Read MorePaul McCaffery is a 10-year testicular cancer survivor living in Scotland. Paul talks about catching his testicular cancer after seeing a self-exam illustration, being treated with orchidectomy and 2xBEP, having a 4-year-old at the time of diagnosis, nearly using IVF but conceiving naturally at the last minute, hosting the "Check One, Two" podcast, and more!
Read More"Livestrong at the YMCA" offers a comprehensive approach to cancer recovery, combining personalized exercise with peer support to enhance physical and emotional well-being. The program helps survivors regain confidence, return to daily activities, and establish lifelong healthy habits within a supportive community.
Read MoreMike DeJean is a testicular cancer survivor from Louisiana. Mike talks about initially being diagnosed with lymphoma; later finding out that it was actually testicular cancer; having enlarged lymph nodes in his abdomen, neck, and lungs; being treated with VIP chemo; having his RPLND with Dr. Cary at IU, and more!
Read MoreRoberts reiterated that these longstanding recommendations include eating a variety of foods, maintaining a healthy weight, limiting saturated fats, sugars, and sodium, and consuming alcohol in moderation. She stressed that these guidelines are applicable to cancer prevention, during treatment, and in survivorship.
Read MoreKevin Hilden is a testicular cancer survivor living in Arizona. Kevin talks about being diagnosed with testicular cancer in his 40s, having an orchiectomy in 2021 and a retroperitoneal mass show up in 2023, having an RPLND at Indiana University, testosterone, and more!
Read MoreThey are conducting the Bridge Study, partnering with various cancer foundations, including the Testicular Cancer Awareness Foundation, to evaluate the effectiveness of these AI-generated summaries among patients with testicular cancer. Participants will compare original abstracts with AI-generated summaries to assess understandability, preference, and the time taken to comprehend the information.
Read MoreDr. Timothy Clinton is an associate surgeon at Brigham and Women's Hospital, Dana Farber Cancer Institute, and Harvard University. Dr. Clinton talks about performing minimally invasive retroperitoneal lymph node dissections (RPLND), how robotic RPLND compares to open RPLND, risks involved with both options, how candidates are selected for robotic RPLND, and more!
Read More
